Schedule 3 of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (the “Regulations”) sets out how appeals of decisions made by NHS England under the Regulations are to be conducted
This guidance note focuses on matters that have arisen in the past in relation to appeals of applications made pursuant to Regulation 17 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
NHS Resolution response to the consultation on the Framework for Involving Patients in Patient Safety
This is NHS Resolution’s response to the consultation on the proposed Framework for involving patients in patient safety from NHS Improvement. A key part of the NHS Patient Safety Strategy published in July 2019, is the introduction of a framework for Patient Safety Partners to provide …
The aim is to provide information which should be used in conjunction with the Regulations, Directions, Protocol, Determinations and Guidance Note for Parties Involved in Dispute Resolution (see paragraph 11). It is not its function to summarise these documents, which should be referred to before …
On 19 May 2020, NHS Resolution amended the guidance issued to parties involved in PCD cases regarding submissions and evidence in order to facilitate the efficient and effective determination of disputes. The guidance (as detailed below) is set-out in first-step letters to parties seeking submissions.
This guidance note is on Regulation 44 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013.
This guidance note is on Regulation 24 of the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013.
This Guidance Note is for general information purposes only. It is not exhaustive but does cover the essential elements needed for parties involved with pharmacy appeals.